CORRELATION OF SERUM ZINC LEVELS WITH SEVERITY AND DISEASE ACTIVITY IN VITILIGO PATIENTS AT SANJIWANI GIANYAR HOSPITAL

Sayu Widiawati, Made Budiani, Pradnya Iswara

Abstract


Vitiligo is autoimmune disease, characterized by well defined milky-white macule, caused by destruction of melanocyte selectively. Management of vitiligo is still challenging due to the pathogenesis is not yet fully understood, and vitiligo can caused significant psychological distress to the patients. Several studies reveal the role of zinc as an important element in the prevention and treatment of vitiligo based on zinc's function as an antiapoptotic, as a bull against free radicals, and as an important element in melanogenesis by stimulating cell mediated immunity activity, zinc and alpha melanocyte stimulating hormone. We conducted an analytical cross-sectional study that aims to determine the correlation between plasma zinc levels and the severity of vitiligo using the VASI score and vitiligo disease activity calculated based on the VIDA score. The results showed that there was a strong negative correlation between serum zinc levels and the VASI score, with a correlation coefficient or r = -0.668 and p <0.05 and there was a negative correlation between serum zinc levels and the VIDA score with a correlation coefficient (r) = -0.342 and p < 0.05.

Save to Mendeley


Keywords


Vitiligo, VASI, VIDA, Zinc Serum.

Full Text:

PDF

References


Alikhan, A., Felsten L.M., Daly, M., Petronic-Rosic, V. 2011. Vitiligo: A Comprehensive Overview. J Am Acad Dermatol; 65(3): 473-91.

Birlea, S.A., Spritz, R.A., Norris, D.A. 2012. Vitiligo In: Wolff, K., Goldsmith, L.A., Katz, S.I., Gilchrest, B.A., Paller, A.S., Leffell, D.J., Eds. Fitzpatrick’s Dermatology In General Medicine. 8th Ed. New York: McGraw Hill. p.792-803.

Ingordo, V., Lannazzone, S, et al. Dermatology Life Quality Index Score in Vitiligo Patients: A Pilot Study Among Young Italian Males. G Ital Dermatol Venereol. 2011; 146:1-2

Hedayat, K.,Karbashsh, et al. Quality of Life in Patient with Vitilgo: A Cross-Sectional Study Based in Vitiligo Quality of Life Index (VitiQol). Health and Quality of Life Outcomes. 2016; 14: 86

Alghamdi, K.M., Kumar, A., Taieb, A., Ezzedine, K. 2012. Assessment Methods for The Evaluation of Vitiligo. JEADV; 26: 1463-71.

Bagherani, N., Yaghoobi, R., Omidian, M. Hypothesis: Zinc can be effective in treatment of vitiligo. Indian J Dermatol. 2011;56:480-4.

Mohammed, GF., Gomaa, AH. Al-Dhubaibi, MS. Highlights in pathogenesis of vitiligo. World J Clin Cases. 2015;3:221-30

Cohen, B., Elbuluk., et al. Alternatif systemic treatments for vitiligo: A review. Am J Clin Dermatol. 2015;16: 463-74.

Zeng, Q, et al. Decreased copper and zinc in sera of Chinese vitiligo patients: A meta-analysis. J Dermatol. 2014;41:245-51

Bagherani, N., Yaghoobi, R., Omidian, M. Hypothesis: Zinc can be effective in treatment of vitiligo. Indian J Dermatol. 2011; 56 (5):480-84.

Daneshpazhooh M, Mostofizadeh G, Behjati J, Akhyani M, Robati MR. Anti-thyroid peroxidase antibody and vitiligo: A controlled study. BMC Dermatol. 2006;6:3

Arora, PN., et al. Serum zinc level in cutaneus disorder. Med J Armed Force India. 2002; 58:304-6.

Zaki, M., Nada, A., Elshahed, A. Therapeutic of assessment of serum zinc level in patients with vitiligo: A patient controlled prospective study. Dermatology therapy. 2020; 33 (3):1-4.

Yanghoobi R, Omidian M, Bagherani N. Vitiligo : A review of the published work 2011:38:419-31. J Dermatol. 2011:38:419-31.

Mohr N, Petersen J, Kirsten N, Augustin M. Epidemiology of Vitiligo - A Dual Population-Based Approach. Clin Epidemiol. 2021 May 26;13:373-382.

Ezzedine, Khaled & Eleftheriadou, Viktoria & Whitton, Maxine & Geel, Nanja. (2015). Vitiligo. Lancet. 386. 10.

Sanad EM, El-Fallah AA, Al-Doori AR, Salem RM. Serum Zinc and Inflammatory Cytokines in Vitiligo. J Clin Aesthet Dermatol. 2020 Dec;13(12 Suppl 1):S29-S33. Epub 2020 Dec 1.

Helmy MI, Gayyar EL, Hawas S, Eissa AE. Role of oxidative stress in the pathogenesis of vitiligo. J Pan-Arab League Dermatologist. 2004;15:97–105.

Shameer P, Prasad PV, Kaviarasan PK. Serum zinc level in vitiligo: A case control study. Indian J Dermatol Veneol Leprol. 2005;71:206–7.

Pichler R, Sfetsos K, Badics B, Gutenbrunner S, Berg J, Auböck J. Lymphocyte imbalance in vitiligo patients indicated by elevated CD4+/CD8+ T-cell ratio. Wien Med Wochenschr. 2009;159:337–41.

Ongenae K, Van Geel N, Naeyeert JM. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res. 2003;16:90–100.

Burns T, Breathnach S, Cox N, Griffiths C. 7th ed. Vol. 2. Oxford: Blackwell Science; 2004. Rook's Textbook of Dermatology; pp. 53– 7.

Inamadar AC, Palit A. Acrodermatitis entropathica with depigmented skin lesions simulating vitiligo. Pediatr Dermatol. 2007;24:668– 9.

Boisy RE, Spritz RA. Frontiers and controversies in the pathobiology of vitiligo: Separating the wheat from chaff. Exp Dermatol. 2009;18:583–5.

Inamadar AC, Palit A. Acrodermatitis entropathica with depigmented skin lesions simulating vitiligo. Pediatr Dermatol. 2007;24:668– 9.




DOI: https://doi.org/10.33508/jwm.v9i1.4230